{"product_id":"rybelsus-semaglutide-tablets-3-mg","title":"Rybelsus (semaglutide) Tablets 3 mg, 30 Tablets Per Bottle","description":"\u003cdiv\u003e\n\u003cdiv data-has-function-call=\"false\" data-format-as-json=\"false\" style=\"--translate-x: 0px; --translate-y: 0px;\" data-draggable=\"\" data-disabled=\"false\" class=\"SUQHo\"\u003e\n\u003cdiv class=\"_7XKOp\"\u003e\n\u003cdiv class=\"-K9ze\"\u003e\n\u003cdiv class=\"mx-1\"\u003e\n\u003cdiv class=\"jjv-K\"\u003e\n\u003cp\u003eRybelsus (semaglutide) Tablets, 3 mg, offer a groundbreaking oral treatment option for adults with type 2 diabetes. Developed by Novo Nordisk, this tablet is the first of its kind, providing an effective solution for enhancing blood sugar control alongside diet and exercise. The 3 mg dosage serves as the initial dose in the treatment regimen, helping patients transition effectively to higher maintenance doses.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduct Name:\u003c\/strong\u003e Rybelsus (semaglutide) Tablets\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Strength:\u003c\/strong\u003e 3 mg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuantity:\u003c\/strong\u003e 30 Tablets per bottle\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUsage:\u003c\/strong\u003e Oral administration\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndication:\u003c\/strong\u003e Initial dose for type 2 diabetes management\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFeatures:\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eConvenient once-daily dosing\u003c\/li\u003e\n\u003cli\u003eInnovative GLP-1 receptor agonist formulation\u003c\/li\u003e\n\u003cli\u003eEnhances patient compliance with oral delivery\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSemaglutide, the active ingredient in Rybelsus, is a GLP-1 receptor agonist that mimics the natural hormone GLP-1. It works by increasing insulin secretion, decreasing glucagon secretion, and slowing gastric emptying. These actions combine to improve blood glucose levels and may also aid in weight reduction.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing:\u003c\/strong\u003e Start with one 3 mg tablet orally once daily for 30 days before transitioning to higher doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e Take on an empty stomach, at least 30 minutes before the first meal of the day with no more than 4 ounces of plain water.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSwallowing:\u003c\/strong\u003e Tablet should be swallowed whole—do not split, crush, or chew.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsistency:\u003c\/strong\u003e Take at the same time each day for optimal results.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFollow-up:\u003c\/strong\u003e Transition to a higher dose after 30 days as directed by your healthcare provider.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eThyroid Tumors:\u003c\/strong\u003e Contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePancreatitis:\u003c\/strong\u003e Monitor for symptoms of pancreatitis; discontinue if suspected.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Considerations:\u003c\/strong\u003e Caution in patients with renal impairment; monitor renal function.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Discontinue use if there's a suspected allergic reaction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Nursing:\u003c\/strong\u003e Not recommended during pregnancy or breastfeeding.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon:\u003c\/strong\u003e Nausea, vomiting, diarrhea, abdominal pain, and decreased appetite.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious:\u003c\/strong\u003e Hypoglycemia (especially when combined with insulin or sulfonylureas), pancreatitis, acute kidney injury, and severe allergic reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRybelsus (semaglutide) Tablets 3 mg provide an accessible and effective entry point for type 2 diabetes management, empowering patients with an impactful oral therapy option that fits seamlessly into daily routines under guidance from healthcare providers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Novo Nordisk","offers":[{"title":"Default Title","offer_id":53337611796798,"sku":"00169-4303-30","price":129729.99,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0872\/3408\/5182\/files\/Rybelsus-_semaglutide_-Tablets-3-mg.jpg?v=1776773779","url":"https:\/\/himkhand.com\/products\/rybelsus-semaglutide-tablets-3-mg","provider":"Himkhand","version":"1.0","type":"link"}